Legal briefings from the world's leading law firms
Life science
Found 22 legal briefings
Chemical reaction: record fine for industrial spying in the Hungarian pharmaceutical sector
A court in Hungary has awarded a record fine for industrial spying after former managers of a Hungarian pharmaceutical company were held liable for breach of trade secrets and ordered to pay record damages. This briefing from Schoenherr outlines what is known so far.
Law Firm: Schoenherr | Published: 16 January 2012 | Practice Area: Life science
Rating: 
1 person found this useful
Life sciences and health industries in China - November update
This briefing summarises the latest business, regulatory and legal developments in China for drug, device, life science and health care companies. Included are details on the finalised five year plan for healthcare reform and a large-scale survey on traditional Chinese medicine resources.
Law Firm: Reed Smith | Published: 13 December 2011 | Practice Area: Health Care
Rating: 1 person found this useful
UK Supreme Court gives gene-patenting boost to bioinformatics industry
In a surprise u-turn, the UK Supreme Court in HGS v Eli Lily overturned the Court of Appeal and Patents Court to uphold the validity of a patent for the encoding of nucleotide. Eversheds provides the full background to the case and comments as to why the decision is a significant one.
Law Firm: Eversheds | Published: 09 December 2011 | Practice Area: Life science
Rating: 2 people found this useful
How the new Russian public health laws will affect the pharmaceutical and medical market
New Russian public health laws due to come into effect on 1 Jan 2012, reflect an unprecedented surge in interest following the first proposals to amend Russia's core legislation on public health protection. This briefing outlines the far-reaching consequences for both industry players and the public...view abstract
Law Firm: Goltsblat BLP | Published: 23 November 2011 | Practice Area: Health Care
Rating: 1 person found this useful
Human embryo patenting – a new way to be human?
On 18 October 2011, the Court of Justice of the EU handed down its long-awaited decision in Oliver Brüstle v Greenpeace. To the dismay of the biotech industry, Eversheds reports on how the decision effectively prohibits the patenting of any inventions derived from human embryos.
Law Firm: Eversheds | Published: 17 November 2011 | Practice Area: Life science
Rating: 2 people found this useful
Earn-outs during the acquisition of a business – everyone's a winner?
An earn-out is a means of ensuring that buyers do not overpay for (and sellers do not undersell) businesses that may be difficult to value upfront. In this briefing, Wragge & Co analyse the implications for buyers and sellers of businesses, and offer some practical action points to consider.
Law Firm: Wragge & Co | Published: 15 November 2011 | Practice Area: Mergers & Acquisitions
Rating: 3 people found this useful
Brave new world: UK Supreme Court finds gene sequence 'capable of industrial application'
The Supreme Court today handed down its judgment in Eli Lilly v HGS overturning the lower courts' finding that HGS's patent lacked industrial applicability. The case is now likely to return to the Court of Appeal. Wragge & Co's IP specialists outline the case's background and wider implications.
Law Firm: Wragge & Co | Published: 02 November 2011 | Practice Area: Life science
Rating: 3 people found this useful
10% tax on intellectual property - will your business benefit from the Patent Box?
Taxation of intellectual property is back in the spotlight with the publication of the Government's proposals which detail how the 10% tax rate, or patent box, will work. This briefing from Wragge & Co looks at why overall there is good news for innovative businesses subject to UK corporation tax.
Law Firm: Wragge & Co | Published: 21 June 2011 | Practice Area: Patents
Rating: 1 person found this useful
Patents court changing attitude towards making generics ‘clear the way’
Nabarro looks at a recent case that gives the first signs that the UK may be about to dismantle the hurdle – unknown in mainland Europe – of ‘clearing the way’, which is put in the way of the launch of a generic pharmaceutical product.
Law Firm: Nabarro | Published: 26 May 2011 | Practice Area: Life science
Rating: 1 person found this useful
The Bribery Act – how will it impact the pharmaceutical industry?
At a time when the value of emerging markets to the pharmaceutical industry is increasing, the global reach of the Bribery Act 2010 is one of a number of good reasons why the new legislation merits particular attention. Taylor Wessing reports.
Law Firm: Taylor Wessing | Published: 11 May 2011 | Practice Area: Health Care
Rating: 1 person found this useful
Find a legal briefing
Categories related to Life science
As a member of Legal Week Law you will receive free access to our library of legal briefings from world’s leading law firms. Briefings are easy to find and constantly being updated. You can also discover what briefings your peers in other companies are looking at.
|
|
Featured Law Firms
© Incisive Media Investments Limited 2012, Published by Incisive Financial Publishing Limited, Haymarket House, 28-29 Haymarket, London SW1Y 4RX, are companies registered in England and Wales with company registration numbers 04252091 & 04252093.